Latest lung cancers Stories
-- Plans to Initiate Clinical Studies of Proprietary CAR-T Cell Immunotherapy for Selected Solid Tumors -- SHANGHAI, Nov.
PF-06463922, an investigational drug being developed by Pfizer Inc., has the potential to become a new treatment option for patients who have lung cancer harboring abnormalities in the ALK gene.
New research has revealed why some lung cancers are undetected by radiograph and helped to identify the type of people who may be at risk of this form of the disease.
A new study led by researchers at Mount Sinai School of Medicine indicates that CT scans are more effective than traditional lung cancer detection methods at identifying aggressive lung cancers in their most treatable stages.
A new study led by researchers at Mount Sinai School of Medicine indicates that CT scans are more effective than traditional lung cancer detection methods at identifying aggressive lung cancers
Growth rates of lung cancers found by annual rounds of computed tomography (CT) screening are important for determining the usefulness and frequency of screening, as well as for determining the treatment.
Smoking is a well-known risk factor for lung cancer, but about 25% of all lung cancer patients have never smoked. According to this study, a gene fusion event could explain a significant proportion of these lung cancer cases, and may serve as a target for new therapies.
DAYTON, Ohio, June 21 /PRNewswire/ -- Riverain MedicalÂ® announced today that the U.S. Food and Drug Administration (FDA) has granted approval for the newest version of the OnGuard(TM) Chest X-ray Computer-Aided Detection (CAD) technology.
Although more than two fifths of lung cancers are diagnosed in patients over 70, data from clinical trials on the safest and most effective treatments for this age group are scarce.